Neonatal drug trials: impact of EU and US paediatric regulations
about
Drug-induced renal damage in preterm neonates: state of the art and methods for early detectionNeonatal drug therapy: The first frontier of therapeutics for childrenDrug versus placebo randomized controlled trials in neonates: A review of ClinicalTrials.gov registry.Antimicrobial dosing in neonates.Therapeutic guidelines for prescribing antibiotics in neonates should be evidence-based: a French national survey.Evaluating the Relationship between Vancomycin Trough Concentration and 24-Hour Area under the Concentration-Time Curve in Neonates.
P2860
Neonatal drug trials: impact of EU and US paediatric regulations
description
im Mai 2014 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 03 May 2014
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2014
@uk
name
Neonatal drug trials: impact of EU and US paediatric regulations
@en
Neonatal drug trials: impact of EU and US paediatric regulations
@nl
type
label
Neonatal drug trials: impact of EU and US paediatric regulations
@en
Neonatal drug trials: impact of EU and US paediatric regulations
@nl
prefLabel
Neonatal drug trials: impact of EU and US paediatric regulations
@en
Neonatal drug trials: impact of EU and US paediatric regulations
@nl
P2860
P50
P1476
Neonatal drug trials: impact of EU and US paediatric regulations
@en
P2093
Claudia Pansieri
P2860
P356
10.1136/ARCHDISCHILD-2013-305900
P577
2014-05-03T00:00:00Z